Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
Login to My Account page
This meeting took place in 2017
For a complete list of the meetings for the upcoming/current season, see our meeting list. or search for a meeting.
Engineered Cells and Tissues as Platforms for Discovery and Therapy (K1)
Organizer(s) Laura E. Niklason, Milica Radisic and Nenad Bursac
March 9 12, 2017
Fairmont Copley Plaza Boston, Massachusetts USA
Discounted Abstract Deadline: Nov 9, 2016
Abstract Deadline: Dec 13, 2016
Scholarship Deadline: Nov 9, 2016
Discounted Registration Deadline: Jan 13, 2017
Sponsored by Editas Medicine, Inc. Juno Therapeutics, Merck & Co. Inc. and Thermo Fisher Scientific Inc.
Summary of Meeting:
Tissue engineering, cell therapies and regenerative medicine have witnessed accelerated progress over the past decade. Fueled by fundamental discoveries in iPS, progenitor, and developmental cell biology, cells are now used as building blocks to create model systems, as testing platforms for drug interventions and as active therapeutics. High-throughput production of various types of “microtissues” or “organoids” is making increasing contributions to our understanding of human development, disease and repair. This Keystone Symposia meeting will highlight these rapidly emerging cell-based tools for fundamental and applied discovery. Culture systems ranging from simple cell cluster organoids, to highly advanced cell-electronic composites, will be discussed. In addition, the encouraging progress that is being made in cell-based therapies across a range of organs and diseases will be featured. The goal of this meeting is to provide a state-of-the-art review of both pluripotent and differentiated cells as tools for discovery and therapy. A broad range of cell types and therapeutic areas will be included.
No registration fees are used to fund entertainment or alcohol at this conference
Conference Program Print | View meeting in 12 hr (am/pm) time
The meeting will begin on Thursday, March 9 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Sunday, March 12 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Monday, March 13 in order to fully experience the meeting.
THURSDAY, MARCH 9
* Laura E. Niklason. Yale University, USA
Amir Ali Khan. University of Sharjah, United Arab Emirates
Unravelling the Gene Expression Profiles of the Early Differentiation of Mesenchymal Stem Cells into Neural Lineage
Sijie Sun. University of Washington, USA
Bioengineering 3D Human Skin Equivalent with Perfused Microvascular Network to Study Host-Viral Interactions During Infection
Christopher Hubert. Cleveland Clinic, Lerner Research Institute, USA
Modeling Glioblastoma through Cancer Stem Cell Organoids
Anastasia Korolj. University of Toronto, Canada
Biomimetic Curvature in Cell Culture Platform Improves Podocyte Differentiation in vitro
Sara Nunes Vasconcelos. University of Toronto, Canada
Diabetes Impairs Arterio-Venous Specification in Engineered Vascular Tissues in a Perivascular Cell Recruitment-Dependent Manner
Ryan LaRanger. University of Texas Southwestern Medical Center, USA
Engineering Reconstituted Decellularized Mouse Lungs with Conditionally Reprogrammed Human Bronchial Epithelial Cells